NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms
- PMID: 11154736
- DOI: 10.1016/s0009-2797(00)00199-x
NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms
Abstract
NAD(P)H:quinone oxidoreductase 1 (NQO1) is an obligate two-electron reductase that is involved in chemoprotection and can also bioactivate certain antitumor quinones. This review focuses on detoxification reactions catalyzed by NQO1 and its role in antioxidant defense via the generation of antioxidant forms of ubiquinone and vitamin E. Bioactivation reactions catalyzed by NQO1 are also summarized and the development of new antitumor agents for the therapy of solid tumors with marked NQO1 content is reviewed. NQO1 gene regulation and the role of the antioxidant response element and the xenobiotic response element in transcriptional regulation is summarized. An overview of genetic polymorphisms in NQO1 is presented and biological significance for chemoprotection, cancer susceptibility and antitumor drug action is discussed.
Similar articles
-
Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1.Clin Cancer Res. 2004 May 1;10(9):3147-55. doi: 10.1158/1078-0432.ccr-03-0411. Clin Cancer Res. 2004. PMID: 15131056
-
Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones.Biochem Pharmacol. 2001 Jun 15;61(12):1509-16. doi: 10.1016/s0006-2952(01)00631-1. Biochem Pharmacol. 2001. PMID: 11377380
-
A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.Clin Cancer Res. 1998 Dec;4(12):3083-8. Clin Cancer Res. 1998. PMID: 9865924
-
NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer.J Med Chem. 2018 Aug 23;61(16):6983-7003. doi: 10.1021/acs.jmedchem.8b00124. Epub 2018 May 7. J Med Chem. 2018. PMID: 29712428 Review.
-
Regulation of genes encoding NAD(P)H:quinone oxidoreductases.Free Radic Biol Med. 2000 Aug;29(3-4):254-62. doi: 10.1016/s0891-5849(00)00306-3. Free Radic Biol Med. 2000. PMID: 11035254 Review.
Cited by
-
The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis.Br J Cancer. 2013 Sep 3;109(5):1325-37. doi: 10.1038/bjc.2013.357. Epub 2013 Jul 16. Br J Cancer. 2013. PMID: 23860519 Free PMC article.
-
New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors.J Mol Histol. 2006 Sep;37(5-7):203-18. doi: 10.1007/s10735-006-9043-8. Epub 2006 Jul 26. J Mol Histol. 2006. PMID: 16868862 Review.
-
The Microbial Mechanisms of a Novel Photosensitive Material (Treated Rape Pollen) in Anti-Biofilm Process under Marine Environment.Int J Mol Sci. 2022 Mar 30;23(7):3837. doi: 10.3390/ijms23073837. Int J Mol Sci. 2022. PMID: 35409199 Free PMC article.
-
Molecular mechanisms mediating the effect of mono-(2-ethylhexyl) phthalate on hormone-stimulated steroidogenesis in MA-10 mouse tumor Leydig cells.Endocrinology. 2010 Jul;151(7):3348-62. doi: 10.1210/en.2010-0010. Epub 2010 May 12. Endocrinology. 2010. PMID: 20463053 Free PMC article.
-
Activation of NQO-1 mediates the augmented contractions of isolated arteries due to biased activity of soluble guanylyl cyclase in their smooth muscle.Naunyn Schmiedebergs Arch Pharmacol. 2018 Nov;391(11):1221-1235. doi: 10.1007/s00210-018-1548-7. Epub 2018 Jul 30. Naunyn Schmiedebergs Arch Pharmacol. 2018. PMID: 30062552
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous